l carnitine tmao koeth 2013 nature medicine Gut microbiota metabolism of l-carnitine and cardiovascular risk JCI - l-Carnitine in omnivorous
JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2




